ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer’s disease in APP/PS-1 mice-Reference-Cited by-同舟云学术

ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer’s disease in APP/PS-1 mice

Published:2023-09-02 Issue:9 Volume:49 Page:559-571
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Chen Mu-Han¹,Liu Xin-Ze¹,Qu Xiu-Wu²,Guo Rui-Bo¹,Zhang Lu¹,Kong Liang¹,Yu Yang¹,Liu Yang¹,Zang Juan¹,Li Xiu-Ying²,Li Xue-Tao¹

Affiliation:

1. School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, P.R. China

2. Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on the Chronic Inflammation, Shanxi University of Chinese Medicine, Jinzhong, P.R. China

Funder

China Postdoctoral Science Foundation

the Doctoral Startup Foundation of Liaoning Province

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2023.2252062

Reference53 articles.

1. 2016 Alzheimer's disease facts and figures

2. The present and future of pharmacotherapy of Alzheimer’s disease: A comprehensive review

3. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

4. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases

5. Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application strategy of liposomes in organ targeting therapy;WIREs Nanomedicine and Nanobiotechnology;2024-03

2. Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases;Pharmaceutics;2024-03-01